Castle Biosciences Stock Tumbles Following Guidance Concerns

InvestingJan 13 15:36 ET

Express News | Castle Biosciences Shares Are Trading Lower After the Company Reported Preliminary FY24 Financial Results

BenzingaJan 13 10:24 ET

Castle Biosciences | 8-K: Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results

SECJan 13 07:27 ET · Announcements

BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsJan 13 05:32 ET · Ratings

Castle Biosciences Reports Preliminary 2024 Results: Expects $320M-$330M In Annual Revenue (+50% YoY), 96,071 Total Tests Delivered (+36% YoY), And $293M In Cash And Investments

BenzingaJan 13 03:09 ET

Castle Biosciences Positioned for Growth After Novitas Resolution and Focus on Core Franchises

TipRanksJan 13 00:55 ET